Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01202864 · ClinicalTrials.gov registry record
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 6,000
- Enrollment target
NCT01202864: Completed study, sponsored by University of Cincinnati.
NCT01202864 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 6,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01202864 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 6,000 participants
- Enrollment target
Study Summary
The purpose of this study is to find risk factors for hemorrhagic stroke, specifically intracerebral hemorrhage (ICH), among Caucasians, African Americans, and Hispanics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2010-08-01 |
| Est. Completion | 2017-08-01 |
What the finished NCT01202864 record still lists
NCT01202864 is an observational study that tracks outcomes without assigning an intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01202864 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01202864 about?
NCT01202864 is a clinical study titled "Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)". The purpose of this study is to find risk factors for hemorrhagic stroke, specifically intracerebral hemorrhage (ICH), among Caucasians, African Americans, and Hispanics.
What is the current status of trial NCT01202864?
This trial is currently completed. The enrollment target is 6,000 participants. The study started on 2010-08-01. Estimated completion is 2017-08-01.
Who is sponsoring clinical trial NCT01202864?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI